PharmaGend Global Medical Services Pte. Ltd.February 1, 2019

FDA 483 - PharmaGend Global Medical Services Pte. Ltd. - February 01, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PharmaGend Global Medical Services Pte. Ltd.

Record Details

During an inspection of Strides Pharma Global Pte Limited in Singapore, the FDA observed deficiencies in control procedures for manufacturing processes, specifically concerning a deficient hold time study protocol. Additionally, the firm's written procedures for cleaning and maintenance were found to lack sufficient detail, particularly regarding the justification of swab sampling locations for equipment cleaning validation.

Company: PharmaGend Global Medical Services Pte. Ltd.
Inspection Date: February 1, 2019
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
Person: Anastasia M. Shields (Consumer Safety Officer )

Open in Dashboard

ID · 5140edc9-8fca-4280-9e31-5e66344fce88